These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19172524)

  • 1. Acute profound thrombocytopenia with second exposure to eptifibatide associated with a strong antibody reaction.
    Attaya S; Kanthi Y; Aster R; McCrae K
    Platelets; 2009 Feb; 20(1):64-7. PubMed ID: 19172524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute profound thrombocytopenia associated with readministration of eptifibatide: case report and review of the literature.
    Russell KN; Schnabel JG; Rochetto RP; Tanner MC
    Pharmacotherapy; 2009 Jul; 29(7):867-74. PubMed ID: 19558261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa.
    Bougie DW; Wilker PR; Wuitschick ED; Curtis BR; Malik M; Levine S; Lind RN; Pereira J; Aster RH
    Blood; 2002 Sep; 100(6):2071-6. PubMed ID: 12200368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Megakaryocyte impairment by eptifibatide-induced antibodies causes prolonged thrombocytopenia.
    Greinacher A; Fuerll B; Zinke H; Müllejans B; Krüger W; Michetti N; Motz W; Schwertz H
    Blood; 2009 Aug; 114(6):1250-3. PubMed ID: 19429867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eptifibatide-induced acute profound thrombocytopenia: a case report.
    Graidis C; Golias C; Dimitriadis D; Dimitriadis G; Bitsis T; Dimitrelos I; Tsiakou A; Charalabopoulos K
    BMC Res Notes; 2014 Feb; 7():107. PubMed ID: 24564943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eptifibatide-induced thrombocytopenia and thrombosis.
    Epelman S; Nair D; Downey R; Militello M; Askari AT
    J Thromb Thrombolysis; 2006 Oct; 22(2):151-4. PubMed ID: 17008982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and time course of thrombocytopenia with abciximab and eptifibatide in patients undergoing percutaneous coronary intervention.
    Fahdi IE; Saucedo JF; Hennebry T; Ghani M; Sadanandan S; Garza-Arreola L
    Am J Cardiol; 2004 Feb; 93(4):453-5. PubMed ID: 14969621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of two platelet glycoprotein IIb/IIIa inhibitors, eptifibatide and abciximab: outcomes, complications and thrombocytopenia during percutaneous coronary intervention.
    Suleiman M; Gruberg L; Hammerman H; Aronson D; Halabi M; Goldberg A; Grenadier E; Boulus M; Markiewicz W; Beyar R
    J Invasive Cardiol; 2003 Jun; 15(6):319-23. PubMed ID: 12777670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eptifibatide-Induced Profound Thrombocytopenia After Percutaneous Intervention for Acute Coronary Syndrome: A Challenging Clinical Scenario.
    Bhatia N; Sawyer RD; Ikram S
    Methodist Debakey Cardiovasc J; 2017; 13(4):248-252. PubMed ID: 29744018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombocytopenia and Thromboses in Myocardial Infarction Associated with Eptifibatide-Dependent Activating Antiplatelet Antibodies.
    Puram RV; Erdil RM; Weber BN; Knelson EH; Van Beuningen AM; Wallwork R; Gilyard SN; Curtis BR; Ranganathan R; Leaf RK; Malhotra R
    Thromb Haemost; 2020 Jul; 120(7):1137-1141. PubMed ID: 32483771
    [No Abstract]   [Full Text] [Related]  

  • 11. Immediate coronary artery bypass surgery after platelet inhibition with eptifibatide: results from PURSUIT. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrelin Therapy.
    Dyke CM; Bhatia D; Lorenz TJ; Marso SP; Tardiff BE; Hogeboom C; Harrington RA
    Ann Thorac Surg; 2000 Sep; 70(3):866-71; discussion 871-2. PubMed ID: 11016325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eptifibatide-Induced Thrombocytopenia--When Inhibitor Turns Killer.
    Pothineni NV; Watts TE; Ding Z; Dai Y; Deshmukh AJ
    Am J Ther; 2016; 23(1):e298-9. PubMed ID: 24368608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible thrombocytopenia associated with eptifibatide.
    Yoder M; Edwards RF
    Ann Pharmacother; 2002 Apr; 36(4):628-30. PubMed ID: 11918511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eptifibatide-induced thrombocytopenia.
    Refaat M; Smith AJ; Edmundowicz D
    J Thromb Thrombolysis; 2008 Apr; 25(2):204-6. PubMed ID: 18008040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reopro, and Eptifibatide.
    Batchelor WB; Tolleson TR; Huang Y; Larsen RL; Mantell RM; Dillard P; Davidian M; Zhang D; Cantor WJ; Sketch MH; Ohman EM; Zidar JP; Gretler D; DiBattiste PM; Tcheng JE; Califf RM; Harrington RA
    Circulation; 2002 Sep; 106(12):1470-6. PubMed ID: 12234950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute profound thrombocytopenia associated with eptifibatide therapy.
    Nagge J; Jackevicius C; Dzavik V; Ross JR; Seidelin P
    Pharmacotherapy; 2003 Mar; 23(3):374-9. PubMed ID: 12627937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eptifibatide: a review of its use in patients with acute coronary syndromes and/or undergoing percutaneous coronary intervention.
    Goa KL; Noble S
    Drugs; 1999 Mar; 57(3):439-62. PubMed ID: 10193692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of eptifibatide and acute profound thrombocytopenia.
    Hongo RH; Brent BN
    Am J Cardiol; 2001 Aug; 88(4):428-31. PubMed ID: 11545770
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe thrombocytopenia possibly related to readministration of eptifibatide.
    Paradiso-Hardy FL; Madan M; Radhakrishnan S; Hurden S; Cohen EA
    Catheter Cardiovasc Interv; 2001 Sep; 54(1):63-7. PubMed ID: 11553950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eptifibatide: a potent inhibitor of the platelet receptor integrin glycoprotein IIb/IIIa.
    O'Shea JC; Tcheng JE
    Expert Opin Pharmacother; 2002 Aug; 3(8):1199-210. PubMed ID: 12150697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.